Tuberculosis News and Research

Latest Tuberculosis News and Research

WHO hands over management of world's largest public collection of TB strains to ITM in Antwerp

The World Health Organisation handed over the management of the world's largest public collection of tuberculosis strains to the Institute of Tropical Medicine in Antwerp. These TB-strains play a key role in supporting scientific research into infectious diseases, particularly towards a better understanding of the TB bacterium's drug resistance.

13 Dec 2013

UCSF receives $15M grant to help three dozen countries eliminate malaria

UC San Francisco's Global Health Group has received a $15 million grant from the Bill & Melinda Gates Foundation for a pioneering effort to help nearly three dozen countries eliminate malaria within their borders.

13 Dec 2013

Results-Based Financing for Health can get 20% more health care with same funds

Countries and major donors are changing the way they finance maternal and child, malaria, tuberculosis and HIV/AIDS health programs in low-income countries to increase their impact.

11 Dec 2013

Otsuka, Lundbeck to develop investigational vaccine candidate for Alzheimer's disease

H. Lundbeck A/S (Lundbeck) and Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announced that they will further expand their collaboration to include the development of Lu AF20513, an investigational vaccine candidate for Alzheimer's disease.

11 Dec 2013

Study finds large degree of genetic variation amongst M. tuberculosis in humans in Zambia

In Zambia, the incidence of all forms of human tuberculosis is estimated to be 444 per 100,000. There is also a high incidence of HIV and AIDS in the country. In the Kafue area, a high incidence of Mycobacterium bovis in both cattle and the Kafue lechwe antilope has been detected. This bacterium can infect humans and has been found in humans in the studied region of Namwala. Mycobacterium tuberculosis, which is the main cause of human tuberculosis, has also been detected in cattle in this region.

10 Dec 2013

Janssen announces first-of-its-kind pediatric HIV treatment donation program

Janssen, the pharmaceutical companies of Johnson & Johnson, today announced a first-of-its-kind pediatric HIV treatment donation program to improve access to the company's approved HIV medicines for children and adolescents failing HIV treatment in sub-Saharan Africa.

9 Dec 2013

Ancon Technologies unveils new cancer-screening device

Ancon Technologies, a company devoted to finding new ways to beat cancer, recently unveiled a new cancer-screening device to the public, the NBT detector. The company's latest product aims to bring cancer detection to the next level: it uses Nanoparticle Biomarker Tagging technology to identify cancer biomarkers in exhaled air.

6 Dec 2013

TB vaccine may help prevent multiple sclerosis

A vaccine used to prevent tuberculosis in other parts of the world may help prevent multiple sclerosis in people who show the beginning signs of the disease, according to a new study published in the December 4, 2013, online issue of Neurology, the medical journal of the American Academy of Neurology.

5 Dec 2013

Tackling orphan diseases: an interview with Damian Marron, CEO, TxCell

The exact definition of orphan diseases varies depending on where you are in the world. In the EU it's defined as a prevalence of less than 1 in 2,000, which equates to about 250,000 patients across the EU.

4 Dec 2013

Lucane Pharma, Medunik Canada to offer new therapeutic option for patients suffering from UCD

Medunik Canada, a pharmaceutical company specialized in orphan drugs and Lucane Pharma, a French niche pharmaceutical company, announced the conclusion of an exclusive collaboration agreement.

4 Dec 2013

Pyridomycin turns out to be a lethal weapon against TB

Technology has made it possible to synthesize increasingly targeted drugs. But scientists still have much to learn from Mother Nature. Pyridomycin, a substance produced by non-pathogenic soil bacteria, has been found to be a potent antibiotic against a related strain of bacteria that cause tuberculosis.

4 Dec 2013

Novartis to present updates on broad cancer portfolio at ASH and SABCS symposiums

Novartis will present updates on its broad cancer portfolio with more than 240 abstracts at the upcoming American Society of Hematology (ASH) annual meeting and CTRC-AACR San Antonio Breast Cancer Symposium (SABCS).

4 Dec 2013

AHF commends donors for rallying to pledge financial support for Global Fund

AIDS Healthcare Foundation (AHF), the largest global AIDS organization, today heartily praised donor countries for rallying to pledge financial support for the Global Fund to Fight AIDS, TB, and Malaria.

4 Dec 2013

EU pledges over $500 million to fight AIDS, TB and malaria

The European Union today announced at the Global Fund's Replenishment Conference in Washington, DC, new support of over US $500 million to fight AIDS, tuberculosis and malaria for the 2014-2016 period. The conference takes place just one day after World AIDS Day.

3 Dec 2013

U.S. Administration to provide $5 billion to the Global Fund to Fight AIDS, Tuberculosis and Malaria

In an address recognizing World AIDS Day, President Barack Obama announced today that the U.S. Administration will commit up to $5 billion to the Global Fund to Fight AIDS, Tuberculosis and Malaria over the next three years. Specifically, he said the United States will contribute $1 for every $2 provided by other donors worldwide through 2016, up to $5 billion.

3 Dec 2013

Newly identified protein could prove promising new drug target for AIDS

Researchers have identified a protein that causes loss of function in immune cells combatting HIV. The scientists report in a paper appearing online Dec. 2 in the Journal of Clinical Investigation that the protein, Sprouty-2, is a promising target for future HIV drug development, since disabling it could help restore the cells' ability to combat the virus that causes AIDS.

2 Dec 2013

WHO releases new report on spinal cord injury

As many as 500 000 people suffer a spinal cord injury each year. People with spinal cord injuries are 2 to 5 times more likely to die prematurely, with worse survival rates in low- and middle-income countries. The new WHO report, "International perspectives on spinal cord injuries", summarizes the best available evidence on the causes, prevention, care and lived experience of people with spinal cord injury.

2 Dec 2013

World AIDS Day: (RED) invites the world to join in fight against AIDS

World AIDS Day marks a time to celebrate how far we've come in the fight to end AIDS, as well as a time to shine a global spotlight on the monumental, historical opportunity now upon us to deliver the world's first AIDS Free Generation in over 30 years.

30 Nov 2013

Medical Research Council should do more in the development of gold standard for clinical trial design

More should be done to celebrate the role of one of Britain’s leading institutions, the Medical Research Council, in the development of the gold standard for clinical trial design. Sir Iain Chalmers, writing in the Journal of the Royal Society of Medicine, questions the apparent reluctance of the MRC to take credit for its ground-breaking work in the design and management of randomised multicentre controlled clinical trials in the 1950s.

28 Nov 2013

UK to fund over 70 new Centres for Doctoral Training

Details of how a -350 million fund will be used to train over 3,500 postgraduate students in engineering and physical sciences, will be announced today by Universities and Science Minister, David Willetts.

28 Nov 2013

Tuberculosis News and Research

Latest Tuberculosis News and Research

WHO hands over management of world's largest public collection of TB strains to ITM in Antwerp

UCSF receives $15M grant to help three dozen countries eliminate malaria

Results-Based Financing for Health can get 20% more health care with same funds

Otsuka, Lundbeck to develop investigational vaccine candidate for Alzheimer's disease

Study finds large degree of genetic variation amongst M. tuberculosis in humans in Zambia

Janssen announces first-of-its-kind pediatric HIV treatment donation program

Ancon Technologies unveils new cancer-screening device

TB vaccine may help prevent multiple sclerosis

Tackling orphan diseases: an interview with Damian Marron, CEO, TxCell

Lucane Pharma, Medunik Canada to offer new therapeutic option for patients suffering from UCD

Pyridomycin turns out to be a lethal weapon against TB

Novartis to present updates on broad cancer portfolio at ASH and SABCS symposiums

AHF commends donors for rallying to pledge financial support for Global Fund

EU pledges over $500 million to fight AIDS, TB and malaria

U.S. Administration to provide $5 billion to the Global Fund to Fight AIDS, Tuberculosis and Malaria

Newly identified protein could prove promising new drug target for AIDS

WHO releases new report on spinal cord injury

World AIDS Day: (RED) invites the world to join in fight against AIDS

Medical Research Council should do more in the development of gold standard for clinical trial design

UK to fund over 70 new Centres for Doctoral Training

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Tuberculosis News and Research

Latest Tuberculosis News and Research

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in